ROSY-D: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab and Are Judged by the Investigator to Clinically Benefit From Continued Treatment.
Datos básicos
Objetivos del proyecto
Objetivo Principal: Proporcionar de forma continua el tratamiento del estudio a los pacientes que sigan beneficiándose de él al término de un estudio clínico, al tiempo que se vigila la seguridad y la tolerabilidad. Objetivos Secundarios: No aplica
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ASTRAZENECA AB C/O FORTREA
Cita
ROSY-D: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab and Are Judged by the Investigator to Clinically Benefit From Continued Treatment. (D4191C00137). ASTRAZENECA AB C/O FORTREA. 2023IP:ÓSCAR JOSÉ JUAN VIDAL.
Portal de investigación